November 1, 2010
Beating the FLU – a Good read for those with a Disablity
- /
Every year some 24,000 Americans die from influenza infection, according to the U.S. Centers for Disease Control and Prevention. Last…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
November 1, 2010
Investigators Recruiting for Trial Studying Safety of Adding BG00012 to MS Treatments
- /
- /
Oct 29, 2010 Summary:Investigators are recruiting 100 people with relapsing-remitting MS nationwide to participate in a study to determine the…
November 1, 2010
Blood Test Now Available to Help Diagnose MS
- /
- /
Article source : The MSFYi e-newsletter provided by the MS Foundation An assay now commercially available throughout most of the…
November 1, 2010
Aussie News: Researchers to shine spotlight on MS causes
- /
Nov 1, 2010 The Federal Government has awarded north Queensland’s James Cook University (JCU) $180,000 over the next three years…
October 31, 2010
FDA approves drug for the “Pseudobulbar Effect” –
- /
- /
Avanir Drug Nuedexta Wins FDA Approval for Uncontrolled Laughing, Crying By Rob Waters – Oct 29, 2010 Avanir Pharmaceuticals Inc. won U.S. approval for…
October 28, 2010
A comprehensive overview of the eight FDA-approved disease-modifying therapies used to slow MS activity (including the newly approved oral therapy, Gilenya), and initial findings on many of the experimental treatments in development for the treatment of MS
- /
- /
- /
Information provided by: Cherie C. Binns RN BS MSCN From the MS Association of America’s Motivator Summer/Fall 2010 issue Based on…
October 27, 2010
MS Patients Find Comfort, Flexibility In Yoga
- /
Experts say with the right supervision, exercise can help manage symptoms of multiple sclerosis, and a special Staten Island yoga…
October 27, 2010
MSF Cruise For a Cause® CELEBRATES ITS 10TH YEAR OF CRUISING ABOARD THE OASIS OF THE SEAS
- /
This is a promotion for the MS Foundation’s Cruise for a Cause. The largest and most revolutionary cruise ship in…
October 26, 2010
Early Treatment With Glatiramer Acetate Improved Outcomes in CIS (Clinically Isolated Syndrome)
- /
- /
October 25, 2010 By: SHARON WORCESTER, Internal Medicine News Digital Network Patients with clinically isolated syndrome who receive early treatment…
October 26, 2010
Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
- /
- /
- /
October 26, 2010 TERACLES is the First Phase III Study of an Oral Drug as an Add-On to Standard Therapy…
